Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


UPDATE: Needham On CryoLife Price Target Raise Post-Earnings: Firm Sees Sustained Double-Digit Revenue Growth Supported By Increasing Momentum From New JOTEC Products: NEXUS, AMDS, & On-X; Notes Organic Rev Growth To 38.2% CC 2Q21 Vs. 4.4% CC In 1Q21


Benzinga | Jul 30, 2021 12:52PM EDT

UPDATE: Needham On CryoLife Price Target Raise Post-Earnings: Firm Sees Sustained Double-Digit Revenue Growth Supported By Increasing Momentum From New JOTEC Products: NEXUS, AMDS, & On-X; Notes Organic Rev Growth To 38.2% CC 2Q21 Vs. 4.4% CC In 1Q21






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC